US 8840868
Non-invasive detection of complement-mediated inflammation using CR2-targeted nanoparticles
granted A61KA61K49/16A61K49/1812
Quick answer
US patent 8840868 (Non-invasive detection of complement-mediated inflammation using CR2-targeted nanoparticles) held by The Regents of the University of Colorado, a Body Corporate expires Mon Sep 18 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of Colorado, a Body Corporate
- Grant date
- Tue Sep 23 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 18 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 7
- CPC classes
- A61K, A61K49/16, A61K49/1812, A61K49/1863, A61K49/1866